Related Experiment Video

Updated: May 13, 2026

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
07:02

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

MicroRNA-33a functions as a bone metastasis suppressor in lung cancer by targeting parathyroid hormone related

Po-Lin Kuo1, Szi-Hui Liao, Jen-Yu Hung

  • 1Institute of Clinical Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.

Biochimica Et Biophysica Acta
|March 6, 2013
PubMed
Abstract

Insights

MicroRNA-33a (miR-33a) suppresses lung cancer bone metastasis by targeting parathyroid hormone-related protein (PTHrP). This microRNA acts as a tumor suppressor, inhibiting osteoclast formation and bone resorption.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Bone metastasis is a frequent complication of lung cancer, associated with poor prognosis.
  • MicroRNAs (miRNAs) play a crucial role in regulating cancer progression and metastasis.

Purpose of the Study:

  • To investigate the role of miR-33a in lung cancer bone metastasis.
  • To identify the molecular targets of miR-33a involved in osteolytic bone metastasis.

Main Methods:

  • Real-time PCR was used to assess miR-33a and anti-miR-33a expression.
  • Luciferase assays were performed to validate direct targeting.
  • ELISA kits measured secreted factors involved in osteoclastogenesis.

Main Results:

  • miR-33a directly targets parathyroid hormone-related protein (PTHrP), a key stimulator of osteoclastic bone resorption.
  • Downregulation of miR-33a in lung cancer cells correlates with increased PTHrP expression.
  • miR-33a reintroduction reduced osteoclastogenesis activators (RANKL, M-CSF) and increased osteoclastogenesis inhibitor (OPG) production, decreasing IL-8 secretion and bone resorption.

Conclusions:

  • miR-33a acts as a tumor suppressor by inhibiting osteoclastogenesis through PTHrP repression.
  • miR-33a may serve as a prognostic biomarker for lung cancer patients.

More Related Videos

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library08:40

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library

Published on: April 6, 2012

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...